학술논문
A40 IBD PATIENTS RECEIVING INFLIXIMAB IN COMBINATION WITH AN IMMUNOMODULATOR ARE LESS LIKELY TO DEVELOP SECONDARY LOSS OF RESPONSE.
Document Type
Article
Author
Source
Journal of the Canadian Association of Gastroenterology; 2019 Supplement, Vol. 2, p80-81, 2p
Subject
Language
ISSN
25152092